Literature DB >> 17260302

New cycloartane glycosides from Cimicifuga dahurica.

W Ye, J Zhang, C T Che, T Ye, S Zhao.   

Abstract

Two new cylcoartane glycosides along with a known compound, 12beta-hydroxycimigenol 3- O-alpha- L-arabinopyranoside, were isolated from the rhizomes of Cimicifuga dahurica (Ranunculaceae). The structures of the new compounds were elucidated as cimigenol 3- O-alpha- L-arabinopyranoside and 25- O-acetylcimigenol 3- O-alpha- L-arabinopyranoside on the basis of chemical and spectral evidence.

Entities:  

Year:  1999        PMID: 17260302     DOI: 10.1055/s-2006-960865

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  5 in total

1.  Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cells.

Authors:  Linda Saxe Einbond; Ye Wen-Cai; Kan He; Hsan-au Wu; Erica Cruz; Marc Roller; Fredi Kronenberg
Journal:  Phytomedicine       Date:  2007-11-05       Impact factor: 5.340

2.  Cycloartane Triterpenes from the Aerial Parts of Actaea racemosa.

Authors:  Ayano Imai; David C Lankin; Dejan Nikolić; Soyoun Ahn; Richard B van Breemen; Norman R Farnsworth; James B McAlpine; Shao-Nong Chen; Guido F Pauli
Journal:  J Nat Prod       Date:  2016-01-13       Impact factor: 4.050

3.  Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa).

Authors:  Sachiko Tsukamoto; Maki Aburatani; Tomihisa Ohta
Journal:  Evid Based Complement Alternat Med       Date:  2005-04-20       Impact factor: 2.629

4.  Cimicifoetisides A and B, two cytotoxic cycloartane triterpenoid glycosides from the rhizomes of Cimicifuga foetida, inhibit proliferation of cancer cells.

Authors:  Li-Rong Sun; Chen Qing; Yan-Li Zhang; Shu-Yu Jia; Zhong-Rong Li; Shen-Ji Pei; Ming-Hua Qiu; Michael L Gross; Samuel X Qiu
Journal:  Beilstein J Org Chem       Date:  2007-01-31       Impact factor: 2.883

5.  Antitumor activity and mechanisms of action of total glycosides from aerial part of Cimicifuga dahurica targeted against hepatoma.

Authors:  Ze Tian; Jianyong Si; Qi Chang; Liang Zhou; Shilin Chen; Peigen Xiao; Erxi Wu
Journal:  BMC Cancer       Date:  2007-12-31       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.